Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Current Protocols in Toxicology
|
February 11, 2014
Assessment of drug transporter function using fluorescent cell imaging
Kristin M Bircsak, Christopher J Gibson, Robert W Robey, et al.
Neurobiology of Disease
|
July 21, 2009
Progress towards a cellular neurobiology of reading disability
Lisa A Gabel, Christopher J Gibson, Jeffrey R Gruen, et al.
Leukemia & Lymphoma
|
November 13, 2019
Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of <i>de novo</i> MDS
Adam S Sperling, Matthew Leventhal, Christopher J Gibson, et al.
The New England Journal of Medicine
|
June 9, 2016
INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status
Kunal P Patel, Anand Vaidya, Christopher J Gibson, et al.
Journal of Medicinal Chemistry
|
January 5, 2026
Modeling Metabolite Kinetics with a Partial Differential Equation-Based Hepatic Sinusoidal Model and MALDI-Mass Spectrometry Imaging of Verapamil and Its Metabolites
Rachel J Parise, Bingming Chen, Christopher J Gibson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 13, 2014
MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells
Xia Wen, Christopher J Gibson, Ill Yang, et al.
Haematologica
|
January 13, 2018
Association of mutations with morphological dysplasia in <i>de novo</i> acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities
Olga K Weinberg, Christopher J Gibson, Traci M Blonquist, et al.
JCI Insight
|
May 8, 2026
Clonal hematopoiesis in lung adenocarcinoma pathogenesis
Tiziana Parisi, Blanca Santibanez Ocampo, Jacob Adelman, et al.
American Journal of Hematology
|
April 4, 2017
NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification
Olga K Weinberg, Christopher J Gibson, Traci M Blonquist, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
November 26, 2013
Regional expression of the BCRP/ABCG2 transporter in term human placentas
Naureen Memon, Kristin M Bircsak, Faith Archer, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Current Protocols in Toxicology
|
February 11, 2014
Assessment of drug transporter function using fluorescent cell imaging
Kristin M Bircsak, Christopher J Gibson, Robert W Robey, et al.
Neurobiology of Disease
|
July 21, 2009
Progress towards a cellular neurobiology of reading disability
Lisa A Gabel, Christopher J Gibson, Jeffrey R Gruen, et al.
Leukemia & Lymphoma
|
November 13, 2019
Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of <i>de novo</i> MDS
Adam S Sperling, Matthew Leventhal, Christopher J Gibson, et al.
The New England Journal of Medicine
|
June 9, 2016
INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status
Kunal P Patel, Anand Vaidya, Christopher J Gibson, et al.
Journal of Medicinal Chemistry
|
January 5, 2026
Modeling Metabolite Kinetics with a Partial Differential Equation-Based Hepatic Sinusoidal Model and MALDI-Mass Spectrometry Imaging of Verapamil and Its Metabolites
Rachel J Parise, Bingming Chen, Christopher J Gibson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 13, 2014
MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells
Xia Wen, Christopher J Gibson, Ill Yang, et al.
Haematologica
|
January 13, 2018
Association of mutations with morphological dysplasia in <i>de novo</i> acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities
Olga K Weinberg, Christopher J Gibson, Traci M Blonquist, et al.
JCI Insight
|
May 8, 2026
Clonal hematopoiesis in lung adenocarcinoma pathogenesis
Tiziana Parisi, Blanca Santibanez Ocampo, Jacob Adelman, et al.
American Journal of Hematology
|
April 4, 2017
NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification
Olga K Weinberg, Christopher J Gibson, Traci M Blonquist, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
November 26, 2013
Regional expression of the BCRP/ABCG2 transporter in term human placentas
Naureen Memon, Kristin M Bircsak, Faith Archer, et al.
Page
of 9